Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyuan Yu

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Zhonghua Yi Xue Za Zhi|April 26, 2014
[Impact of insertion timing of iodophor cotton ball on the control of infection complications after transrectal ultrasound guided prostate biopsy]Li Yu, Lingfei Ma, Hongyuan Yu
Life Sciences|March 17, 2020
Corrigendum to "TIS11D can affect bladder cancer cells by regulating epithelial-mesenchymal transition" [Life Sci. 235 (2019) 116832]Lei Yin, Yang Liu, Hongwei Jing, et al.
Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expressionXianguo Cai, Xianjun Zhang, Licai Mo, et al.
Cancer Management and Research|November 18, 2020
Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein AbundanceJunlong Liu, Xiuyue Yu, Bitian Liu, et al.
Archives of Medical Science : AMS|February 13, 2026
Cyclin-dependent kinase 8/β-catenin signalling contributes to tumourigenesis in prostate cancer and can be regulated by miR-216a-5pTao Hong, Hongyuan Yu, Weilin Li, et al.
Alternative Therapies in Health and Medicine|November 2, 2023
A Survey on the Current Status of Adult External Ventricular Drainage Care: Exploring Content Framework and the Need for Group StandardsYue Sun, Hongyuan Yu, Yangyang Tian, et al.
Oncology Reports|January 3, 2020
Transcription factor RUNX2 regulates epithelial‑mesenchymal transition and progression in renal cell carcinomasBitian Liu, Junlong Liu, Hongyuan Yu, et al.
Colloids and Surfaces. B, Biointerfaces|December 20, 2025
ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancerLi Li, Junxiong Wen, Hao Xu, et al.
FEBS Open Bio|April 12, 2017
Ubiquitin ligase SMURF1 functions as a prognostic marker and promotes growth and metastasis of clear cell renal cell carcinomaMang Ke, Licai Mo, Weilin Li, et al.
Oxidative Medicine and Cellular Longevity|July 22, 2022
Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory NetworkJinling Li, Hongyuan Yu, Jinlong Yao, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Zhonghua Yi Xue Za Zhi|April 26, 2014
[Impact of insertion timing of iodophor cotton ball on the control of infection complications after transrectal ultrasound guided prostate biopsy]Li Yu, Lingfei Ma, Hongyuan Yu
Life Sciences|March 17, 2020
Corrigendum to "TIS11D can affect bladder cancer cells by regulating epithelial-mesenchymal transition" [Life Sci. 235 (2019) 116832]Lei Yin, Yang Liu, Hongwei Jing, et al.
Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expressionXianguo Cai, Xianjun Zhang, Licai Mo, et al.
Cancer Management and Research|November 18, 2020
Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein AbundanceJunlong Liu, Xiuyue Yu, Bitian Liu, et al.
Archives of Medical Science : AMS|February 13, 2026
Cyclin-dependent kinase 8/β-catenin signalling contributes to tumourigenesis in prostate cancer and can be regulated by miR-216a-5pTao Hong, Hongyuan Yu, Weilin Li, et al.
Alternative Therapies in Health and Medicine|November 2, 2023
A Survey on the Current Status of Adult External Ventricular Drainage Care: Exploring Content Framework and the Need for Group StandardsYue Sun, Hongyuan Yu, Yangyang Tian, et al.
Oncology Reports|January 3, 2020
Transcription factor RUNX2 regulates epithelial‑mesenchymal transition and progression in renal cell carcinomasBitian Liu, Junlong Liu, Hongyuan Yu, et al.
Colloids and Surfaces. B, Biointerfaces|December 20, 2025
ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancerLi Li, Junxiong Wen, Hao Xu, et al.
FEBS Open Bio|April 12, 2017
Ubiquitin ligase SMURF1 functions as a prognostic marker and promotes growth and metastasis of clear cell renal cell carcinomaMang Ke, Licai Mo, Weilin Li, et al.
Oxidative Medicine and Cellular Longevity|July 22, 2022
Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory NetworkJinling Li, Hongyuan Yu, Jinlong Yao, et al.
Pageof 5